Long-term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab

Mark Lebwohl, Andrew Blauvelt, Alan Menter, Kim Papp, Abby Jacobson
2019 SKIN The Journal of Cutaneous Medicine  
not available.
doi:10.25251/skin.3.supp.26 fatcat:p2426purmfb2tpgwz3f3aeujoy